Eye Care Stories
Blindness and vision loss impact over 1 billion people around the world. From our first discovery in 1948 at Allergan, now part of AbbVie, see how our scientists are building on a legacy of preserving and protecting vision.
-
Sharpening focus on eye diseases caused by diabetes
The experiences of these AbbVie leaders are aiming to elevate the standard of care for patients with diabetes and vision complications.
Read Article -
A history of discovery: Why we focus on challenging eye care diseases
Look at the science behind helping to prevent vision loss and impairment, a leading cause of disability that affects nearly 30% of the world’s population.
Read Article -
Shining a light on glaucoma and eye health
Helping patients get to a doctor sooner.
Read Article
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2025 AbbVie Inc. North Chicago, Illinois, U.S.A.
